30.04.2015 • NewsDede WillamsBASFcapacity expansion

BASF Trials MDI Precursor Production at Chongqing

BASF has begun trial operations at its 400,000 t/y mononitrobenzene plant at Chongqing, in western China. The new facility will feed the group's integrated MDI complex at the same location. Investment costs for the entire project are pegged at €860 million.

In addition to mononitrobenzene, the site will produce 300,000 t/y of aniline, 400,000 t/y of crude MDI and will also have an MDI splitter with a capacity of 400,000 t/y.

Located in the Chongqing Changshou Chemical Industrial Park, the complex, initially planned to go on stream in 2010, took three and a half years to be approved by Chinese authorities. A planned start-up in 2014 was delayed further by BASF's differences with officials over an increase in gas prices.

MDI is an important component for polyurethanes. BASF is building a new Polyurethane Solutions Systems House at Chongqing.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read